Kevin T Conroy Exact Sciences Corp (EXAS) insider trading activity

EXAS Quotes by TradingView

Kevin T Conroy is President and CEO of EXACT SCIENCES CORP. Currently has a direct ownership of 1.15 Million shares of EXAS, which is worth approximately $50 Million. The most recent transaction as insider was on Jul 01, 2021, when has been sold 7,784 shares (Common Stock) at a price of $123.43 per share, resulting in proceeds of $960,779. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.15M
7.46% 3M change
11.17% 12M change
Total Value Held $50 Million

Kevin T Conroy Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 01 2021
SELL
Open market or private sale
$960,779 $123.43 p/Share
7,784 Reduced 1.04%
737,328 Common Stock
Jun 01 2021
SELL
Open market or private sale
$1,374,624 $111.0 p/Share
12,384 Reduced 1.63%
745,112 Common Stock
May 03 2021
SELL
Open market or private sale
$2,522,172 $131.09 p/Share
19,240 Reduced 2.48%
757,496 Common Stock
Apr 30 2021
BUY
Grant, award, or other acquisition
$21,235 $64.74 p/Share
328 Added 0.04%
776,736 Common Stock
Apr 01 2021
SELL
Open market or private sale
$3,010,487 $132.3 p/Share
22,755 Reduced 2.85%
776,408 Common Stock
Mar 02 2021
SELL
Open market or private sale
$1,355,962 $138.42 p/Share
9,796 Reduced 1.21%
799,163 Common Stock
Mar 01 2021
SELL
Open market or private sale
$4,290,583 $137.11 p/Share
31,293 Reduced 3.82%
788,384 Common Stock
Mar 01 2021
BUY
Exercise of conversion of derivative security
-
20,575 Added 2.48%
808,959 Common Stock
Feb 26 2021
BUY
Exercise of conversion of derivative security
-
9,312 Added 1.12%
819,677 Common Stock
Feb 24 2021
SELL
Open market or private sale
$2,238,046 $136.3 p/Share
16,420 Reduced 1.99%
810,365 Common Stock
Feb 23 2021
BUY
Exercise of conversion of derivative security
-
34,325 Added 3.99%
826,785 Common Stock
Feb 17 2021
SELL
Open market or private sale
$2,257,595 $142.66 p/Share
15,825 Reduced 1.96%
792,460 Common Stock
Feb 16 2021
BUY
Exercise of conversion of derivative security
-
31,132 Added 3.71%
808,285 Common Stock
Feb 05 2021
BUY
Exercise of conversion of derivative security
$99,995 $5.7 p/Share
17,543 Added 2.21%
777,153 Common Stock
Feb 01 2021
SELL
Open market or private sale
$4,189,596 $138.07 p/Share
30,344 Reduced 3.84%
759,610 Common Stock
Jan 04 2021
SELL
Open market or private sale
$4,095,735 $128.74 p/Share
31,814 Reduced 3.71%
825,704 Common Stock
Dec 28 2020
SELL
Bona fide gift
-
35,750 Reduced 4.33%
789,954 Common Stock
Dec 01 2020
SELL
Open market or private sale
$3,812,952 $124.7 p/Share
30,577 Reduced 3.44%
857,518 Common Stock
Nov 02 2020
SELL
Open market or private sale
$3,984,883 $121.42 p/Share
32,819 Reduced 3.56%
888,095 Common Stock
Oct 01 2020
SELL
Open market or private sale
$2,854,394 $104.08 p/Share
27,425 Reduced 2.89%
920,914 Common Stock

Also insider at

EPZM
Epizyme, Inc. Healthcare
Director
ADPT
Adaptive Biotechnologies Corp Healthcare
Director
SLGC
SomaLogic, Inc. Healthcare
Director
ALGN
ALIGN TECHNOLOGY INC Healthcare
KTC

Kevin T Conroy

President and CEO
Madison, WI

Track Institutional and Insider Activities on EXAS

Follow EXACT SCIENCES CORP and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells EXAS shares.

Notify only if

Insider Trading

Get notified when an Exact Sciences Corp insider buys or sells EXAS shares.

Notify only if

News

Receive news related to EXACT SCIENCES CORP

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on EXAS